Compare Edwards Lifesciences Corporation Common Stock (EW) vs Victoria's Secret & Co (VSXY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Edwards Lifesciences Corporation Common Stock vs Victoria's Secret & Co — how do they compare? Edwards Lifesciences Corporation Common Stock trades at $83.78 (market cap $48.56B), while Victoria's Secret & Co trades at $82.21 (market cap $6.91B). The key difference: Edwards Lifesciences Corporation Common Stock is far larger — about 7× Victoria's Secret & Co's market cap, and Victoria's Secret & Co is trading nearer its 52-week high, Edwards Lifesciences Corporation Common Stock nearer its low. Which is the better fit depends on your goals.
| EW | VSXY | |
|---|---|---|
Market Cap | $48.56B | $6.91B |
Volume | 6,520,488 | 1,346,928 |
Sector | Health | Consumer Cyclical |
52-Week High | $95.18 | $99.97 |
52-Week Low | $72.65 | $28.25 |
Enterprise Value | $45.01B | $9.29B |
Typical Hold Time | — | 34 Days |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
No Aura AI signal available yet.
Victoria's Secret (VSXY) trades at $85.79, up 0.83% with a bullish technical signal and strong earnings beat history. The stock shows robust profitability with 45.27% ROE and 39.57% gross margins, though net margins remain modest at 5.47%. Recent news highlights fashion show expansion and global growth initiatives, with institutional buying supporting positive sentiment. The current price sits near the consensus target of $86.80, with support at $85 and resistance at $87.
VSXY presents a compelling growth story with accelerating fundamentals and analyst support, though rich valuation at 19.33 P/E and competitive retail pressures warrant caution. The 2026 outlook improvement and consistent earnings beats provide upside potential, while margin pressures and consumer spending volatility represent key risks for investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →About Victoria's Secret & Co
Victoria's Secret & Co is a specialty retailer of lingerie, pajamas, and beauty products with prestige fragrances and body care. It serves customers at its Lingerie and Beauty stores around the globe and online enabling them to shop the brand anywhere and anytime.
Read more on VSXY →
